"Currently there are only two antivirals that might be effective in the event of a bird flu pandemic: Tamiflu from Roche and GSK’s Relenza. Roche appears unable to produce its antiviral Tamiflu in sufficient quantities, and there is already evidence that the H5N1 virus has developed resistance to Tamiflu. GSK’s inhaled antiviral, Relenza, has been ordered in significant quantities by several governments, including one order for 7 million doses bought by the German government."
http://www.sanmanagement.com/f/art/1f.htm
BTA Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held